Curi Bio’s integrated Cells, Systems, and Data ecosystem now scales to 96-well throughput, unlocking industrial-scale Non-Animal Model (NAM) workflows for pharma drug discovery.
Curi Bio,...
Strategic acquisition strengthens InSphero’s global position as the market leader in predictive in vitro modeling and high-content imaging services
InSphero AG, a global leader in advanced...